Pomanda estimates the enterprise value of MEDNEO DIAGNOSTICS UK LIMITED at £16.2m based on a Turnover of £19m and 0.85x industry multiple (adjusted for size and gross margin).
medneo diagnostics uk limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of MEDNEO DIAGNOSTICS UK LIMITED at £0 based on an EBITDA of £-964.7k and a 6.58x industry multiple (adjusted for size and gross margin).
medneo diagnostics uk limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of MEDNEO DIAGNOSTICS UK LIMITED at £0 based on Net Assets of £-490.3k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medneo Diagnostics Uk LimitedOverview
Medneo Diagnostics Uk Limited is a live company located in london, W1W 6QP with a Companies House number of 11851997. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2019, it's largest shareholder is
medneo uk limited
with a 100% stake. Medneo Diagnostics Uk Limited is a young,
mid sized company, Pomanda has estimated its turnover at
£19m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Medneo Diagnostics Uk Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
5 Strong
0 Regular
6 Weak
Size
annual sales of £19m, make it larger than the average company (£798.1k)
£19m - Medneo Diagnostics Uk Limited
£798.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 65%, show it is growing at a faster rate (6.5%)
65% - Medneo Diagnostics Uk Limited
6.5% - Industry AVG
Production
with a gross margin of 52.7%, this company has a lower cost of product (36.5%)
52.7% - Medneo Diagnostics Uk Limited
36.5% - Industry AVG
Profitability
an operating margin of -5.1% make it less profitable than the average company (5.6%)
-5.1% - Medneo Diagnostics Uk Limited
5.6% - Industry AVG
Employees
with 141 employees, this is above the industry average (19)
141 - Medneo Diagnostics Uk Limited
19 - Industry AVG
Pay Structure
on an average salary of £61k, the company has a higher pay structure (£27k)
£61k - Medneo Diagnostics Uk Limited
£27k - Industry AVG
Efficiency
resulting in sales per employee of £134.7k, this is more efficient (£51.5k)
£134.7k - Medneo Diagnostics Uk Limited
£51.5k - Industry AVG
Debtor Days
it gets paid by customers after 38 days, this is later than average (22 days)
38 days - Medneo Diagnostics Uk Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 6 days, this is quicker than average (17 days)
6 days - Medneo Diagnostics Uk Limited
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Medneo Diagnostics Uk Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 5 weeks, this is less cash available to meet short term requirements (101 weeks)
5 weeks - Medneo Diagnostics Uk Limited
101 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 119.1%, this is a higher level of debt than the average (27.9%)
119.1% - Medneo Diagnostics Uk Limited
27.9% - Industry AVG
MEDNEO DIAGNOSTICS UK LIMITED financials
EXPORT
Medneo Diagnostics Uk Limited's latest turnover from December 2023 is £19 million and the company has net assets of -£490.3 thousand. According to their latest financial statements, Medneo Diagnostics Uk Limited has 141 employees and maintains cash reserves of £340.5 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Turnover
18,985,712
15,827,645
10,169,101
4,211,268
941,496
Other Income Or Grants
Cost Of Sales
8,987,263
6,964,966
6,793,393
2,809,588
620,155
Gross Profit
9,998,449
8,862,679
3,375,709
1,401,679
321,341
Admin Expenses
10,971,502
9,202,451
4,862,329
3,601,346
1,947,245
Operating Profit
-973,053
-339,772
-1,486,620
-2,199,667
-1,625,904
Interest Payable
8,228
4,408
4,683
5,182
Interest Receivable
5,787
1,199
94
135
Pre-Tax Profit
-975,494
-344,180
-1,485,421
-2,204,256
-1,630,951
Tax
Profit After Tax
-975,494
-344,180
-1,485,421
-2,204,256
-1,630,951
Dividends Paid
Retained Profit
-975,494
-344,180
-1,485,421
-2,204,256
-1,630,951
Employee Costs
8,601,431
6,634,198
1,540,963
614,545
233,840
Number Of Employees
141
118
63
26
10
EBITDA*
-964,735
-334,110
-1,484,449
-2,199,611
-1,625,904
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Tangible Assets
12,237
13,591
7,354
1,963
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
12,237
13,591
7,354
1,963
Stock & work in progress
Trade Debtors
2,013,477
1,847,306
1,611,143
664,457
143,608
Group Debtors
Misc Debtors
201,906
54,346
23,931
54,306
115,881
Cash
340,533
1,374,305
807,796
151,505
35,901
misc current assets
total current assets
2,555,916
3,275,957
2,442,870
870,268
295,390
total assets
2,568,153
3,289,548
2,450,224
872,231
295,390
Bank overdraft
Bank loan
Trade Creditors
164,743
233,319
139,002
34,536
6,433
Group/Directors Accounts
1,562,661
1,451,775
699,182
4,160,332
1,705,244
other short term finances
hp & lease commitments
other current liabilities
1,331,050
1,119,261
782,667
512,569
61,135
total current liabilities
3,058,454
2,804,355
1,620,851
4,707,437
1,772,812
loans
153,528
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
153,528
total liabilities
3,058,454
2,804,355
1,620,851
4,707,437
1,926,340
net assets
-490,301
485,193
829,373
-3,835,206
-1,630,950
total shareholders funds
-490,301
485,193
829,373
-3,835,206
-1,630,950
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Operating Activities
Operating Profit
-973,053
-339,772
-1,486,620
-2,199,667
-1,625,904
Depreciation
8,318
5,662
2,171
56
Amortisation
Tax
Stock
Debtors
313,731
266,578
916,311
459,274
259,489
Creditors
-68,576
94,317
104,466
28,103
6,433
Accruals and Deferred Income
211,789
336,594
270,098
451,434
61,135
Deferred Taxes & Provisions
Cash flow from operations
-1,135,253
-169,777
-2,026,196
-2,179,348
-1,817,825
Investing Activities
capital expenditure
-6,964
-11,899
-7,562
-2,019
Change in Investments
cash flow from investments
-6,964
-11,899
-7,562
-2,019
Financing Activities
Bank loans
Group/Directors Accounts
110,886
752,593
-3,461,150
2,455,088
1,705,244
Other Short Term Loans
Long term loans
-153,528
153,528
Hire Purchase and Lease Commitments
other long term liabilities
share issue
6,150,000
1
interest
-2,441
-4,408
1,199
-4,589
-5,047
cash flow from financing
108,445
748,185
2,690,049
2,296,971
1,853,726
cash and cash equivalents
cash
-1,033,772
566,509
656,291
115,604
35,901
overdraft
change in cash
-1,033,772
566,509
656,291
115,604
35,901
medneo diagnostics uk limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medneo diagnostics uk limited. Get real-time insights into medneo diagnostics uk limited's credit score, group structure and payment trends.
Perform a competitor analysis for medneo diagnostics uk limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in W1W area or any other competitors across 12 key performance metrics.
medneo diagnostics uk limited Ownership
MEDNEO DIAGNOSTICS UK LIMITED group structure
Medneo Diagnostics Uk Limited has no subsidiary companies.
The sole shareholder of Medneo Diagnostics Uk Limited is Medneo Uk Limited.
medneo uk limited
100%
medneo diagnostics uk limited directors
Medneo Diagnostics Uk Limited currently has 3 directors.
The longest serving directors include
Mr Stuart Webb (Nov 2020) and
Mr Daniel Hefel (Jul 2022).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medneo diagnostics uk limited.
medneo diagnostics uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDNEO DIAGNOSTICS UK LIMITED. This can take several minutes, an email will notify you when this has completed.
medneo diagnostics uk limitedCompanies House Filings - See Documents
